Testing every kilogram of every incoming container is practically impossible for facilities handling hundreds of drums, bags, or containers daily. Instead, pharmaceutical companies rely on scientifically designed statistical sampling plans, robust Good Manufacturing Practices (GMP), and comprehensive risk assessment methodologies to obtain representative samples that accurately reflect the quality of the entire lot.

This June 2026 notification signals a maturing pharmacovigilance framework. For stakeholders from large-scale manufacturers and CMOs to frontline healthcare providers, the message is clear: scientific justification is the only path to market survival. This article breaks down the ban and explores the strategic shifts necessary for industry compliance.

This vital commitment is maintained by a strong, globally consistent system of strict monitoring, high standards, and clear accountability. This system of excellent regulation is the foundation for companies like Walter Healthcare. While some might see regulation as a complicated bureaucracy that slows things down, responsible drug manufacturers recognize it as the necessary protection. It is the crucial element that safeguards patient health and the trustworthiness of life-s

This blog explores how the fixed-dose combination of Pantoprazole 40 mg + Domperidone 10 mg delivers a dual-action advantage in GERD and acid-related disorders. By combining Pantoprazole’s powerful acid suppression with Domperidone’s prokinetic action, it ensures faster relief, improved gastric motility, and long-lasting patient comfort. The article highlights its clinical superiority over monotherapy, regulatory acceptance, and formulation excellence by Walter Healthcare, ma

Ensuring every pharmaceutical label meets CDSCO’s strict standards isn’t optional; it’s the key to patient safety, regulatory approval,...